133 related articles for article (PubMed ID: 33497822)
1. Mechanisms of drug solubilization by polar lipids in biorelevant media.
Katev V; Vinarov Z; Tcholakova S
Eur J Pharm Sci; 2021 Apr; 159():105733. PubMed ID: 33497822
[TBL] [Abstract][Full Text] [Related]
2. Micellar solubilization of poorly water-soluble drugs: effect of surfactant and solubilizate molecular structure.
Vinarov Z; Katev V; Radeva D; Tcholakova S; Denkov ND
Drug Dev Ind Pharm; 2018 Apr; 44(4):677-686. PubMed ID: 29164955
[TBL] [Abstract][Full Text] [Related]
3. Effect of Surfactant-Bile Interactions on the Solubility of Hydrophobic Drugs in Biorelevant Dissolution Media.
Vinarov Z; Katev V; Burdzhiev N; Tcholakova S; Denkov N
Mol Pharm; 2018 Dec; 15(12):5741-5753. PubMed ID: 30351956
[TBL] [Abstract][Full Text] [Related]
4. Influence of Hydrophobic and Hydrophilic Chain Length of C
Kroll P; Exner L; Brandenbusch C; Sadowski G
Mol Pharm; 2023 Feb; 20(2):1296-1306. PubMed ID: 36565283
[TBL] [Abstract][Full Text] [Related]
5. Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs.
Kossena GA; Boyd BJ; Porter CJ; Charman WN
J Pharm Sci; 2003 Mar; 92(3):634-48. PubMed ID: 12587125
[TBL] [Abstract][Full Text] [Related]
6. In vitro digestion testing of lipid-based delivery systems: calcium ions combine with fatty acids liberated from triglyceride rich lipid solutions to form soaps and reduce the solubilization capacity of colloidal digestion products.
Devraj R; Williams HD; Warren DB; Mullertz A; Porter CJ; Pouton CW
Int J Pharm; 2013 Jan; 441(1-2):323-33. PubMed ID: 23178598
[TBL] [Abstract][Full Text] [Related]
7. Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approach.
Kossena GA; Charman WN; Boyd BJ; Dunstan DE; Porter CJ
J Pharm Sci; 2004 Feb; 93(2):332-48. PubMed ID: 14705191
[TBL] [Abstract][Full Text] [Related]
8. Impact of Gut Microbiota-Mediated Bile Acid Metabolism on the Solubilization Capacity of Bile Salt Micelles and Drug Solubility.
Enright EF; Joyce SA; Gahan CG; Griffin BT
Mol Pharm; 2017 Apr; 14(4):1251-1263. PubMed ID: 28186768
[TBL] [Abstract][Full Text] [Related]
9. Biorelevant media simulating fed state intestinal fluids: colloid phase characterization and impact on solubilization capacity.
Kleberg K; Jacobsen F; Fatouros DG; Müllertz A
J Pharm Sci; 2010 Aug; 99(8):3522-32. PubMed ID: 20564382
[TBL] [Abstract][Full Text] [Related]
10. Molecular Dynamics Simulations Reveal Membrane Interactions for Poorly Water-Soluble Drugs: Impact of Bile Solubilization and Drug Aggregation.
Kabedev A; Hossain S; Hubert M; Larsson P; Bergström CAS
J Pharm Sci; 2021 Jan; 110(1):176-185. PubMed ID: 33152373
[TBL] [Abstract][Full Text] [Related]
11. Toward simplified oral lipid-based drug delivery using mono-/di-glycerides as single component excipients.
Ilie AR; Griffin BT; Vertzoni M; Kuentz M; Cuyckens F; Wuyts K; Kolakovic R; Holm R
Drug Dev Ind Pharm; 2020 Dec; 46(12):2051-2060. PubMed ID: 33124918
[TBL] [Abstract][Full Text] [Related]
12. Computational Models of the Gastrointestinal Environment. 2. Phase Behavior and Drug Solubilization Capacity of a Type I Lipid-Based Drug Formulation after Digestion.
Birru WA; Warren DB; Han S; Benameur H; Porter CJ; Pouton CW; Chalmers DK
Mol Pharm; 2017 Mar; 14(3):580-592. PubMed ID: 27936778
[TBL] [Abstract][Full Text] [Related]
13. Effect of lipids on absorption of carvedilol in dogs: Is coadministration of lipids as efficient as a lipid-based formulation?
Alskär LC; Parrow A; Keemink J; Johansson P; Abrahamsson B; Bergström CAS
J Control Release; 2019 Jun; 304():90-100. PubMed ID: 31047962
[TBL] [Abstract][Full Text] [Related]
14. Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion.
Williams HD; Anby MU; Sassene P; Kleberg K; Bakala-N'Goma JC; Calderone M; Jannin V; Igonin A; Partheil A; Marchaud D; Jule E; Vertommen J; Maio M; Blundell R; Benameur H; Carrière F; Müllertz A; Pouton CW; Porter CJ
Mol Pharm; 2012 Nov; 9(11):3286-300. PubMed ID: 23030411
[TBL] [Abstract][Full Text] [Related]
15. Drug solubility in fatty acids as a formulation design approach for lipid-based formulations: a technical note.
Lee YC; Dalton C; Regler B; Harris D
Drug Dev Ind Pharm; 2018 Sep; 44(9):1551-1556. PubMed ID: 29873584
[TBL] [Abstract][Full Text] [Related]
16. Danazol oral absorption modelling in the fasted dog: An example of mechanistic understanding of formulation effects on drug pharmacokinetics.
Pade D; Jamei M; Turner DB; Mistry B; Martinez MN
Eur J Pharm Biopharm; 2019 Aug; 141():191-209. PubMed ID: 31150808
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
Fei Y; Kostewicz ES; Sheu MT; Dressman JB
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
[TBL] [Abstract][Full Text] [Related]
18. Non-ionic dendritic glycerol-based amphiphiles: novel excipients for the solubilization of poorly water-soluble anticancer drug Sagopilone.
Richter A; Wiedekind A; Krause M; Kissel T; Haag R; Olbrich C
Eur J Pharm Sci; 2010 Apr; 40(1):48-55. PubMed ID: 20188825
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the solubilization of steroids by bile salt micelles.
Cai X; Grant DJ; Wiedmann TS
J Pharm Sci; 1997 Mar; 86(3):372-7. PubMed ID: 9050808
[TBL] [Abstract][Full Text] [Related]
20. From Quantum Chemistry to Prediction of Drug Solubility in Glycerides.
Alsenz J; Kuentz M
Mol Pharm; 2019 Nov; 16(11):4661-4669. PubMed ID: 31518142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
